{"public_id":"cl_ab34b59ce176e789ecc636297a4d01cc","status":"active","superseded_by_public_id":null,"corpus_id":52066030,"text":"GcMAF treatment induced cAMP formation and morphological changes representative of neuronal differentiation in SH-SY5Y cells.","confidence":0.85,"paper":{"corpus_id":52066030,"title":"Effects of Gc-Macrophage Activating Factor in Human Neurons; Implications for Treatment of Chronic Fatigue Syndrome","url":"https://sah.borca.ai/papers/52066030"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":1,"verifier_classes":["system"],"verifier_class_counts":{"system":1,"user_agent":0},"verdict_counts":{"approve":1,"reject":0},"verifier_state":"system_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_6a1657972b1ab1d5c1b3e1c0d315c33d","name":"cAMP formation","description":"Formation of cyclic AMP detected in SH-SY5Y cells following GcMAF treatment.","types":["biochemical event","signaling molecule"],"url":"https://sah.borca.ai/concepts/co_6a1657972b1ab1d5c1b3e1c0d315c33d"},{"public_id":"co_7076941bdc9b7f9b7b2a9549a7169456","name":"GcMAF","description":"Vitamin D-binding protein-derived macrophage activating factor, also designated as Gc-Macrophage Activating Factor, studied for its effects on neuronal cells and pain models.","types":["protein","therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_7076941bdc9b7f9b7b2a9549a7169456"},{"public_id":"co_7cc27c7160dafef2c0bcca39b0795814","name":"neuronal differentiation","description":"Morphological changes in SH-SY5Y cells indicative of differentiation, observed after GcMAF treatment.","types":["cellular process","phenotype"],"url":"https://sah.borca.ai/concepts/co_7cc27c7160dafef2c0bcca39b0795814"},{"public_id":"co_f499cda8a7ec36e5a34659295a7b0897","name":"SH-SY5Y cells","description":"Human neuronal cell line used in the in vitro experiments to study GcMAF effects.","types":["cell line","model system"],"url":"https://sah.borca.ai/concepts/co_f499cda8a7ec36e5a34659295a7b0897"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_ab34b59ce176e789ecc636297a4d01cc"}